Navigation Links
Platelet-rich plasma: Does it work?
Date:9/30/2009

ROSEMONT, Ill. Platelet -rich plasma (PRP) is currently used as an alternative treatment method for several common orthopaedic-related sports medicine conditions. According to a new study in the October issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS), early outcomes of PRP appear promising; however, larger clinical studies are still needed to determine the benefits of its use.

"Some believe that PRP may catalyze the body's repair mechanisms at areas of injury, improve healing and shorten recovery time," said study co-author Michael Hall, MD, a senior orthopaedic surgery resident at the NYU Hospital for Joint Diseases in New York. "However, there currently is minimal evidence of this clinically and more research must be performed."

A Simple Process and Procedure

  • Obtaining and utilizing PRP is a relatively simple process: a patient's own blood is placed into a centrifuge that rotates at high speed.
  • This procedure separates the red blood cells from the platelets, which are blood cells that release growth factors that help the body heal itself.
  • Next, the physician takes the platelet-rich portion of this blood (PRP) and injects it directly into the patient's injured area and the treatment is complete.

PRP Used Primarily for Chronic Conditions

PRP treatments have been used for the past two decades to improve wound healing and bone grafting procedures by plastic and maxillofacial (mouth, jaw and neck) surgeons. It is only in recent years that orthopaedic surgeons and sports medicine specialists have utilized this technology.

PRP use in sports medicine primarily has been for the treatment of chronic tendon conditions, but also for acute muscle injuries and for the augmentation of tendon repair in the operating room.

The most common applications include:

  • tennis elbow (lateral epicondylitis);
  • Achilles tendonitis (inflammati
    '/>"/>

Contact: Lauren Pearson
lpearson@aaos.org
847-384-4031
American Academy of Orthopaedic Surgeons
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Do Fad Diets Really Work?
2. How Old Is Too Old to Work?
3. Double Your Income With Thai Yoga Bodywork?
4. Is sex work?
5. Does Antibacterial Soap Work? At Least One Really Does.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... Eric J. Hall, president and chief e...America (AFA) issued the following statement regar...on as part of the new annual wellness for Medicare... Affordable Care Act" that was introduced las...PRWEB) November 21, 2009 -- Eric J. Hall, presiden...
(Date:11/20/2009)...Pioneering Neurologist Closer to Understanding Bra...PRNewswire-USNewswire/ -- Dr. Jeremy Schmahmann, P...d neurologist at the Massachusetts General Hospita...is laboratory,s research on the new field of study...nk Foundation. ,, Dr. Schmahmann is an award-wi...
(Date:11/20/2009)..., WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -... urged the Senate to make essential changes its he... law on abortion funding and conscience protection...migrants and include strong provisions for adequat...te health care bill an "enormous disappointment" t...
(Date:11/20/2009)..., MADISON, N.J., Nov. 20 /PRNewswire-FirstCall/ -...rus may have peaked in late October, but the pande...f illness in all age groups, including the elderly...ncorporated (NYSE: DGX ), the world,s leading pr...ices. ,, In its most recent Quest Diagnostics ...
(Date:11/20/2009)..., HAIFA, Israel, November 20 /PRNewswire-Firs...SL.OB), http://www.CVSLMEDICAL.COM , a leading,de...ogy, today announced that,the company,s Board of D...ns,in Europe, Canada and the Far East for its prop...icable for all angioplasty (PCTA) procedures. ,...
Breaking Medicine News(10 mins):Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2
... Gujarat Government seeks to bring down infant and...lth program. As many as 5,000 // mothers and 72,0...ate. Through this new program named Chiranj... mortality rate to come down to 30 per thousand bi...
...porters of the Communist Party of India-Marxist (C...January 2006. The supporters of the guru are // ...MP Brinda Karat, who leveled charges that the medi...the office of the party. Health Minister ...
...what can be called as a rare feat, cardio-thoracic...ormed surgical correction of a congenital heart de... anesthesia’. // This surgery has so far been done...ng the entire surgery. The sensation of pain would...
...ect injection of chemotherapeutic agents into dire...onal intravenous route, seems to be // associated...ents, according to a latest study. // Ovari...f treatment for all ovarian cancer patients. ...
... incidence of waterborne diseases and food poisoni...ummer. An increase in the number of malaria cases ... cases is hoped to soar particularly, as people wo...bility of a well-developed public health system in...
...ted Kingdom Ministry is planning for reduction of ...re surgery. The Government is planning to reduce t... weeks from time of admission to NHS. Government i...tic and scan tests and also have to wait for speci...
Other Medicine News:Health News:Death Risk Of Ovarian Cancer Reduced By Intraperitoneal Chemotherapy 2Health News:Rise In Waterborne And Malaria Cases Anticipated In Britain 2
(Date:11/20/2009)...Newswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: ...nd Chief Executive Officer, and Greg Browne, Chief...l Piper Jaffray Health Care Conference in New York...The conference session and webcast will be audio o... Jaffray will host a webcast of the presentation l...
(Date:11/20/2009)...ov. 20 BD (Becton, Dicki...he completion of its acquisition of HandyLab, Inc....ps and manufactures molecular diagnostic assays an...HandyLab announced an exclusive agreement for BD t...e HandyLab Jaguar(TM) platform, the first fully in...
(Date:11/20/2009)... 20 Soligenix, Inc. (OTC... formerly known as DOR BioPharma, Inc., a late-sta...has formed a consortium to develop thermostable te...ting vaccines. Soligenix received a $9.4 million g...fectious Diseases (NIAID), a division of the Natio...
Breaking Medicine Technology:Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Unifi Med 5 0 Complete EMR and Practice Management Solution 5426 1Unifi Med 5 0 Complete EMR and Practice Management Solution 5426 2U S Patent Issued for Champions Biotechnologys Lead Oncology Drug 5424 1U S Patent Issued for Champions Biotechnologys Lead Oncology Drug 5424 2U S Patent Issued for Champions Biotechnologys Lead Oncology Drug 5424 3Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast 5422 1Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast 5422 2
...y to Submit a Supplemental New Drug Application to...April 6 Cephalon, Inc . (Nasdaq: CEPH ) today ...ical trial of NUVIGIL(R) (armodafinil) Tablets [C-...ated with jet lag disorder. Based on these findin...Application with the U.S. Food and Drug Administra...
...CORE Phase II Testing Certification with Edifecs C...es that are now required in X12 Version 5010 , , ...y that it will, together with its partners CAQH an...s and lessons learned from the CORE Phase II Certi...andated 5010 Rules, in a presentation at the HIMSS...
Other Medicine Technology:Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 2Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 3Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 4Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 2Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 3Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 4Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 5
... American standard, corrected curve trial lenses a...ed in Marco refractors and are invaluable in treat...ets of other manufacturers contain a disproportion...which are less expensive to produce, and fewer len...
Marco LM-990A
LM-770 Digital Projection Lensemeter
EPIC
Medicine Products: